DEPACON vs SESQUIENT

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. DEPACON and SESQUIENT are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	DEPACON	SESQUIENT
Rating	72/100	64/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	VALPROATE SODIUM	FOSPHENYTOIN SODIUM
Manufacturer	Abbvie	Lupin
Dosage forms	Injectable	Solution
Drug class	Anti-Epileptic Agent	Anti-Epileptic Agent
Boxed warning	None	None
Half-life	about 9 to 16 hours (the label's mean terminal, or elimination, half-life for valproate monotherapy after oral doses of 250 to 1,000 mg)	—
Treats	—	Seizures, Status Epilepticus

depacon sesquient

Rating

72/100

64/100

Pharmacy pays

—

Type

Active ingredient

VALPROATE SODIUM

FOSPHENYTOIN SODIUM

Manufacturer

Abbvie

Lupin

Dosage forms

Injectable

Solution

Drug class

Anti-Epileptic Agent

Boxed warning

None

Half-life

about 9 to 16 hours (the label's mean terminal, or elimination, half-life for valproate monotherapy after oral doses of 250 to 1,000 mg)

—

Treats

—

Seizures, Status Epilepticus

Frequently asked questions

Which is better-rated, Depacon or Sesquient?

By our independent rating, Depacon scores higher — 3.6 vs 3.2 out of 5 for Sesquient. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Depacon and Sesquient?

Depacon contains Valproate Sodium, while Sesquient contains Fosphenytoin Sodium — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.